Menu

Experience

Carlos Ramirez

    • Metacrine – $85 Million IPO 


    • Neurocrine Partners With Takeda to Address Psychiatric Disorders 


    • Vir Biotechnology - $143 Million IPO 


    • Novo Holdings Leads $72 Million Series E for LanzaTech 


    • ViaCyte: $80 Million Series D Financing 


    • Allogene Therapeutics – $372.6 Million IPO 


    • Atlassian - $531 Million IPO 


    • NantKwest IPO - $238 Million IPO 


    • NantKwest – $238 Million IPO 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • Apigee Completes Initial Public Offering 


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


Contact us

Back to top

© 2021 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.